Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma

American Journal of Obstetrics and Gynecology

Volumn 210, Issue 3, 2014, Pages 255.e1-255.e4

  Kudesia, Rashmi ^a   Singer, Tomer ^a   Caputo, Thomas A ^a   Holcomb, Kevin Michael ^a   Kligman, Isaac ^a   Rosenwaks, Zev ^a   Gupta, Divya ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

endometrial cancer; endometrial hyperplasia; fertility sparing treatment; progestin therapy

Indexed keywords

LEVONORGESTREL; MEGESTROL ACETATE; PROGESTERONE;

ADULT; CANCER THERAPY; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIAL COMPLEX ATYPICAL HYPERPLASIA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; HYSTERECTOMY; INFERTILITY THERAPY; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LIVE BIRTH; MAJOR CLINICAL STUDY; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RETROSPECTIVE STUDY;

ENDOMETRIAL CANCER; ENDOMETRIAL HYPERPLASIA; FERTILITY-SPARING TREATMENT; PROGESTIN THERAPY;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY PRESERVATION; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84894583866     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.11.001     Document Type: Conference Paper

References (24)

1. National Cancer Institute. Surveillance Epidemiology and End Results. Available at: http://seer.cancer.gov/statistics/. Accessed May 15, 2012.
2. National Cancer Institute. Cancer Trends Progress Report - 2011/2012 Update. Bethesda, MD: National Institutes of Health, Department of Health and Human Services; 2012.
3. Sherry B, Blanck HM, Galuska DA, Pan L, Dietz WH, Balluz L. MMWR: vital signs: state-specific obesity prevalence among adults - United States, 2009. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
4. T.J. Mathews, and B.E. Hamilton Delayed childbearing: more women are having their first child later in life. NCHS data brief, number 21 2009 National Center for Health Statistics Hyattsville, MD
5. M.P. Lowe, B.C. Cooper, A.K. Sood, W.A. Davis, C.H. Syrop, and J.I. Sorosky Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia Gynecol Oncol 91 2003 569 572
6. L. Minig, D. Franchi, S. Boveri, C. Casadio, L. Bocciolone, and M. Sideri Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women Ann Oncol 22 2011 643 649
7. M. Signorelli, G. Caspani, C. Bonazzi, V. Chiappa, P. Perego, and C. Mangioni Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases BJOG 116 2009 114 118
8. K. Ushijima, H. Yahata, and H. Yoshikawa et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women J Clin Oncol 25 2007 2798 2803
9. W.H. Gotlieb, M.E. Beiner, and B. Shalmon et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer Obstet Gynecol 102 2003 718 725
10. H.S. Hahn, S.G. Yoon, and J.S. Hong et al. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer Int J Gynecol Cancer 19 2009 1068 1073
11. I.D. Gallos, J. Yap, M. Rajkhowa, D.M. Luesley, A. Coomarasamy, and J.K. Gupta Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis Am J Obstet Gynecol 207 2012 266.e1 266.e12
12. J.L. Hubbs, R.M. Saig, L.N. Abaid, V.L. Bae-Jump, and P.A. Gehrig Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma Obstet Gynecol 121 2013 1172 1180
13. A. Gadducci, N. Spirito, E. Baroni, R. Tana, and A.R. Genazzani The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option Gynecol Endocrinol 25 2009 683 691
14. L. Chiva, F. Lapuente, and L. González-Cortijo et al. Sparing fertility in young patients with endometrial cancer Gynecol Oncol 111 Suppl 2 2008 S101 S104
15. O. Zivanovic, J. Carter, N.D. Kauff, and R.R. Barakat A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer Gynecol Oncol 115 2009 504 509
16. P.T. Ramirez, M. Frumovitz, D.C. Bodurka, C.C. Sun, and C. Levenback Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review Gynecol Oncol 125 2012 477 482
17. C.C. Gunderson, A.N. Fader, K.A. Carson, and R.E. Bristow Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review Gynecol Oncol 125 2012 477 482
18. K.R. Penner, O. Dorigo, and C. Aoyama et al. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy Gynecol Oncol 124 2012 542 548
19. J. Baker, A. Obermair, V. Gebski, and M. Janda Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature Gynecol Oncol 125 2012 263 270
20. C.L. Trimble, J. Kauderer, and R. Zaino et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study Cancer 106 2006 812 819
21. Centers for Disease Control and Prevention American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2010 assisted reproductive technology fertility clinic success rates report 2012 US Department of Health and Human Services Atlanta, GA
22. C. Walsh, C. Holschneider, Y. Hoang, K. Tieu, B. Karlan, and I. Cass Coexisting ovarian malignancy in young women with endometrial cancer Obstet Gynecol 106 2005 693 699
23. J. Reddy, and K. Oktay Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer Fertil Steril 98 2012 1363 1369
24. J.D. Wright, A.M. Buck, M. Shah, W.M. Burke, P.B. Schiff, and T.J. Herzog Safety of ovarian preservation in premenopausal women with endometrial cancer J Clin Oncol 27 2009 1214 1219